Glofitamab in Real Life

14 Jan 20264 min read0 viewsOBSERVATIONAL Trial

GIST

RECRUITING · OBSERVATIONAL · Large B-cell Lymphoma · Enrollment 250 · Sponsor: The Lymphoma Academic Research Organisation

Clinical Editorial

Summary

ClinicalTrials.gov published a clinical update in Critical Care on 14 Jan 2026. The item focuses on Glofitamab in Real Life. Open the detail page to review the full original feed content.

Source Reference

Read the full original publication from the source journal or publisher link below.

DOI

NCT06994169

Open Original Source More Feed Items

Related by Condition/Drug

PLOS ONERelated by Conditionlymphoma

Comparison of dose-adjusted EPOCH-R and R-CHOP in diffuse large B-cell lymphoma with high Ki67 expression: Results from a prospective observational study

Research Highlights • 22 May 2026

ClinicalTrialsRelated by Conditionlymphoma

DOAC Dosing Options in Anticoagulation Prophylaxis for Cancer Outpatients

Critical Care • 05 Feb 2026

BMJ OpenRelated by Conditionlymphoma

Treatment adherence, survival outcomes and barriers to care of non-Hodgkin lymphoma in Northwest Ethiopia: a mixed-methods study

Research Highlights • 11 May 2026

BMJ OpenRelated by Conditionlymphoma

Longitudinal real-world surveillance of infection outcomes in CAR-T and bispecific therapy recipients: the CLARITY study protocol

Research Highlights • 07 May 2026

From CAR-T to CAAR-T: redefining targeting strategies in B-cell malignancies through idiotype-directed cellular therapy

Infectious Disease • 18 May 2026

Mechanisms of First-Line Treatment Resistance in DLBCL

Infectious Disease • 08 May 2026

Feed Metadata

Source

ClinicalTrials.gov